Related Experiment Video
Updated: Aug 11, 2026

Drug Treatment by Central Venous Catheter in a Mouse Model of Angiotensin II Induced Abdominal Aortic Aneurysm and Monitoring by 3D Ultrasound
Published on: August 4, 2022
Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth
O Schouten1, J H H van Laanen, E Boersma
1Department of Vascular Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
Objective:
To evaluate the effect of statins on aneurysm growth in a group of consecutive patients under surveillance for infrarenal aortic aneurysms (AAA).
Materials And Methods:
All patients (59 statin users, 91 non-users) under surveillance between January 2002 and August 2005 with a follow-up for aneurysm growth of at least 12 months and a minimum of three diameter evaluations were retrospectively included in the analysis. Multiple regression analysis, weighted with the number of observations, was performed to test the influence of statins on AAA growth rate.
Results:
During a median period of 3.1 (1.1-13.1) years the overall mean aneurysm growth rate was 2.95+/-2.8 mm/year. Statin users had a 1.16 mm/year lower AAA growth rate compared to non-users (95% CI 0.33-1.99 mm/year). Increased age was associated with a slower growth (-0.09 mm/year per year, p = 0.003). Female gender (+1.82 mm/year, p = 0.008) and aneurysm diameter (+0.06 mm/year per mm, p = 0.049) were associated with increased AAA growth. The use of non-steroidal anti-inflammatory drugs, chronic lung disease, or other cardiovascular risk factors were not independently associated with AAA growth.
Conclusions:
Statins appear to be associated with attenuation of AAA growth, irrespective of other known factors influencing aneurysm growth.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Aneurysm III: Interprofessional Care
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis I: Introduction
Coronary Artery Disease I: Introduction
